Brendan Muldoon

Brendan Muldoon has extensive experience in pharmaceutical research and development, currently serving as the R&D Site Head at Teva Pharmaceuticals. Prior roles include Director of Analytical Development and Director of Formulation Development at Warner Chilcott, as well as Supervisor of Formulation Development. Brendan Muldoon earned a PhD in Pharmaceutics with a focus on Chemistry from Queen's University Belfast between 1995 and 2001.